Understanding Brain Blood Flow in CADASIL

Cerebrovascular reactivity as a VCID biomarker in CADASIL

NIH-funded research University of Wisconsin-Madison · NIH-11194299

This project looks at how blood vessels in the brain react in people with CADASIL, a genetic condition that can lead to stroke and memory problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-11194299 on NIH RePORTER

What this research studies

CADASIL is a genetic condition that can cause strokes and lead to memory and thinking problems. We know that specific changes in a gene called NOTCH3 affect the small blood vessels in the brain. This project will examine how well these small brain blood vessels respond to signals in people with CADASIL, using a measurement called cerebrovascular reactivity (CVR). By studying CVR in adults with CADASIL and NOTCH3 mutations, we hope to find early signs of disease changes before symptoms become noticeable. This work aims to understand how brain blood flow is affected in CADASIL to potentially identify problems sooner.

Who could benefit from this research

Good fit: People with CADASIL who have NOTCH3 mutations, and healthy individuals, are the focus of this research.

Not a fit: Patients without CADASIL or those with different types of dementia may not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could help identify early signs of vascular dementia in CADASIL patients, potentially leading to earlier interventions.

How similar studies have performed: While the specific use of CVR as an early biomarker in CADASIL is being explored, preclinical studies have indicated a link between NOTCH3 mutations and vascular changes, suggesting a strong basis for this approach.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's disease and related dementiaAlzheimer's disease and related disordersAlzheimer's disease or a related dementiaAlzheimer's disease or a related disorderAlzheimer's disease or related dementia
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.